Fresenius Medical Care AG & Co. KGaA (ETR:FME) receives €68.00 price target from Barclays analysts

0

Barclays set a target price of €68.00 ($71.58) on Fresenius Medical Care AG & Co. KGaA (ETR: FMEGet a rating) in a research report released Wednesday morning, Borsen Zeitung reports.

Other stock analysts have also published research reports on the company. Deutsche Bank Rese… set a target price of €58.00 ($61.05) on Fresenius Medical Care AG & Co. KGaA in a Thursday, May 5 research note. Goldman Sachs Group set a target price of €71.00 ($74.74) on Fresenius Medical Care AG & Co. KGaA in a Tuesday, March 22 research note. Berenberg Bank set a target price of €82.20 ($86.53) on Fresenius Medical Care AG & Co. KGaA in a research note on Tuesday. JPMorgan Chase & Co. set a target price of €51.00 ($53.68) on Fresenius Medical Care AG & Co. KGaA in a research note on Tuesday. Finally, Deutsche Bank Aktiengesellschaft set a target price of €58.00 ($61.05) on Fresenius Medical Care AG & Co. KGaA in a Tuesday, March 22 research note.

Action Fresenius Medical Care AG & Co. KGaA opened at €45.02 ($47.39) on Wednesday. The stock has a market capitalization of $13.19 billion and a price-to-earnings ratio of 15.12. The company has a debt ratio of 91.78, a current ratio of 1.26 and a quick ratio of 0.79. The company has a fifty-day moving average price of €56.61 and a 200-day moving average price of €57.55. Fresenius Medical Care AG & Co. KGaA has a 1-year minimum of €43.53 ($45.82) and a 1-year maximum of €71.14 ($74.88).

Fresenius Medical Care AG & Co. KGaA Company Profile (Get a rating)

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, assisting with follow-up and arranging delivery of supplies to the patient’s home; and contracted dialysis services with hospitals in the United States for hospitalized patients with end-stage renal disease (ESRD) and for patients with acute renal failure.

See also



Get news and reviews for Fresenius Medical Care AG & Co. KGaA Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com’s free daily email newsletter .

Share.

Comments are closed.